Khosrotehrani K - Search Results

1

Increased risk for nonmelanoma skin cancers in patients who receive thiopurines for inflammatory bowel disease.

Peyrin-Biroulet L, Khosrotehrani K, Carrat F, Bouvier AM, Chevaux JB, Simon T, Carbonnel F, Colombel JF, Dupas JL, Godeberge P, Hugot JP, Lémann M, Nahon S, Sabaté JM, Tucat G, Beaugerie L; Cesame Study Group. Peyrin-Biroulet L, et al. Among authors: khosrotehrani k. Gastroenterology. 2011 Nov;141(5):1621-28.e1-5. doi: 10.1053/j.gastro.2011.06.050. Epub 2011 Jun 25. Gastroenterology. 2011. PMID: 21708105

2

Significance of erythema nodosum and pyoderma gangrenosum in inflammatory bowel diseases: a cohort study of 2402 patients.

Farhi D, Cosnes J, Zizi N, Chosidow O, Seksik P, Beaugerie L, Aractingi S, Khosrotehrani K. Farhi D, et al. Among authors: khosrotehrani k. Medicine (Baltimore). 2008 Sep;87(5):281-293. doi: 10.1097/MD.0b013e318187cc9c. Medicine (Baltimore). 2008. PMID: 18794711 Free article.

3

Erythema nodosum-like eruption as a manifestation of azathioprine hypersensitivity in patients with inflammatory bowel disease.

de Fonclare AL, Khosrotehrani K, Aractingi S, Duriez P, Cosnes J, Beaugerie L. de Fonclare AL, et al. Among authors: khosrotehrani k. Arch Dermatol. 2007 Jun;143(6):744-8. doi: 10.1001/archderm.143.6.744. Arch Dermatol. 2007. PMID: 17576940

4

Neurofibromatosis 1: analysis of the demand for prenatal diagnosis in a French cohort of 361 patients.

Farhi D, Bastuji-Garin S, Khosrotehrani K, Vidaud D, Bellane C, Revuz J, Wolkenstein P. Farhi D, et al. Among authors: khosrotehrani k. Am J Med Genet A. 2008 Jan 15;146A(2):159-65. doi: 10.1002/ajmg.a.32066. Am J Med Genet A. 2008. PMID: 18076113

5

Clinical risk factors for mortality in patients with neurofibromatosis 1: a cohort study of 378 patients.

Khosrotehrani K, Bastuji-Garin S, Zeller J, Revuz J, Wolkenstein P. Khosrotehrani K, et al. Arch Dermatol. 2003 Feb;139(2):187-91. doi: 10.1001/archderm.139.2.187. Arch Dermatol. 2003. PMID: 12588224

6

[Cutaneous manifestations associated with chronic inflammatory bowel disease].

Farhi D, Cosnes J, Aractingi S, Khosrotehrani K. Farhi D, et al. Among authors: khosrotehrani k. Ann Dermatol Venereol. 2009 Nov;136(11):828-33; 826-7, 834-5. doi: 10.1016/j.annder.2008.10.045. Epub 2009 Apr 21. Ann Dermatol Venereol. 2009. PMID: 19917440 French. No abstract available.

7

Subcutaneous neurofibromas are associated with mortality in neurofibromatosis 1: a cohort study of 703 patients.

Khosrotehrani K, Bastuji-Garin S, Riccardi VM, Birch P, Friedman JM, Wolkenstein P. Khosrotehrani K, et al. Am J Med Genet A. 2005 Jan 1;132A(1):49-53. doi: 10.1002/ajmg.a.30394. Am J Med Genet A. 2005. PMID: 15523617

8

Fetal cell microchimerism in cancer: a meaningful event?

Khosrotehrani K, Aractingi S. Khosrotehrani K, et al. Future Oncol. 2009 Nov;5(9):1441-8. doi: 10.2217/fon.09.111. Future Oncol. 2009. PMID: 19903071 Review.

9

[Gestational microchimerism in human diseases].

Parant O, Khosrotehrani K, Aractingi S. Parant O, et al. Among authors: khosrotehrani k. Presse Med. 2009 Apr;38(4):584-90. doi: 10.1016/j.lpm.2008.05.020. Epub 2008 Nov 25. Presse Med. 2009. PMID: 19036555 Review. French.

10

Two observations raising questions about risk factors of cutaneous necrosis induced by terlipressin (Glypressin).

Mégarbané H, Barete S, Khosrotehrani K, Izzedine H, Moguelet P, Chosidow O, Frances C, Aractingi S. Mégarbané H, et al. Among authors: khosrotehrani k. Dermatology. 2009;218(4):334-7. doi: 10.1159/000195676. Epub 2009 Jan 21. Dermatology. 2009. PMID: 19155616

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

204 results

Search Page